Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Marcocci

Showing results (81-90 of 209) with videos related to

Pageof 21
Sort By:
Endocrine|October 26, 2022
Vitamin D in the older population: a consensus statementAndrea Giustina, Roger Bouillon, Bess Dawson-Hughes, et al.
Molecular and Clinical Oncology|February 23, 2018
A patient with MEN1 and end-stage chronic kidney disease due to Alport syndrome: Decision making on the eligibility of transplantationAntonio Matrone, Alessandro Brancatella, Piero Marchetti, et al.
European Thyroid Journal|April 22, 2016
The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' OrbitopathyLuigi Bartalena, Lelio Baldeschi, Kostas Boboridis, et al.
Expert Review of Endocrinology & Metabolism|February 14, 2019
HRPT2 gene analysis and the diagnosis of parathyroid carcinomaFilomena Cetani, Elena Pardi, Chiara Banti, et al.
The Lancet. Diabetes & Endocrinology|September 30, 2021
Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trialGiulia Lanzolla, Elena Sabini, Marenza Leo, et al.
European Journal of Endocrinology|June 9, 2019
MANAGEMENT OF ENDOCRINE DISEASE: Unmet therapeutic, educational and scientific needs in parathyroid disordersJens Bollerslev, Camilla Schalin-Jäntti, Lars Rejnmark, et al.
European Journal of Endocrinology|June 20, 2017
Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitisIsabella Lupi, Mirco Cosottini, Patrizio Caturegli, et al.
European Journal of Endocrinology|November 30, 2002
Real-time PCR provides evidence for thyrotropin receptor mRNA expression in orbital as well as in extraorbital tissuesPatrizia Agretti, Luca Chiovato, Giuseppina De Marco, et al.
The Journal of Clinical Endocrinology and Metabolism|March 6, 2004
Improvement of growth hormone deficiency in patients with primary hyperparathyroidism after parathyroidectomy: results of a prospective studyElisabetta Cecconi, Maurizio Gasperi, Fausto Bogazzi, et al.
The Journal of Clinical Endocrinology and Metabolism|November 29, 2020
Do the Heterozygous Carriers of a CYP24A1 Mutation Display a Different Biochemical Phenotype Than Wild Types?Alessandro Brancatella, Daniele Cappellani, Martin Kaufmann, et al.
Pageof 21

Showing results (81-90 of 209) with videos related to

Sort By:
Pageof 21
Endocrine|October 26, 2022
Vitamin D in the older population: a consensus statementAndrea Giustina, Roger Bouillon, Bess Dawson-Hughes, et al.
Molecular and Clinical Oncology|February 23, 2018
A patient with MEN1 and end-stage chronic kidney disease due to Alport syndrome: Decision making on the eligibility of transplantationAntonio Matrone, Alessandro Brancatella, Piero Marchetti, et al.
European Thyroid Journal|April 22, 2016
The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' OrbitopathyLuigi Bartalena, Lelio Baldeschi, Kostas Boboridis, et al.
Expert Review of Endocrinology & Metabolism|February 14, 2019
HRPT2 gene analysis and the diagnosis of parathyroid carcinomaFilomena Cetani, Elena Pardi, Chiara Banti, et al.
The Lancet. Diabetes & Endocrinology|September 30, 2021
Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trialGiulia Lanzolla, Elena Sabini, Marenza Leo, et al.
European Journal of Endocrinology|June 9, 2019
MANAGEMENT OF ENDOCRINE DISEASE: Unmet therapeutic, educational and scientific needs in parathyroid disordersJens Bollerslev, Camilla Schalin-Jäntti, Lars Rejnmark, et al.
European Journal of Endocrinology|June 20, 2017
Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitisIsabella Lupi, Mirco Cosottini, Patrizio Caturegli, et al.
European Journal of Endocrinology|November 30, 2002
Real-time PCR provides evidence for thyrotropin receptor mRNA expression in orbital as well as in extraorbital tissuesPatrizia Agretti, Luca Chiovato, Giuseppina De Marco, et al.
The Journal of Clinical Endocrinology and Metabolism|March 6, 2004
Improvement of growth hormone deficiency in patients with primary hyperparathyroidism after parathyroidectomy: results of a prospective studyElisabetta Cecconi, Maurizio Gasperi, Fausto Bogazzi, et al.
The Journal of Clinical Endocrinology and Metabolism|November 29, 2020
Do the Heterozygous Carriers of a CYP24A1 Mutation Display a Different Biochemical Phenotype Than Wild Types?Alessandro Brancatella, Daniele Cappellani, Martin Kaufmann, et al.
Pageof 21